Tech Company Financing Transactions
Tilray Funding Round
Tilray, based in Nanaimo BC, received $47.6 million from private investors.
Transaction Overview
Company Name
Announced On
2/9/2018
Transaction Type
Venture Equity
Amount
$47,630,000
Round
Series A
Investors
Proceeds Purpose
Tilray will use the new funding to increase its existing production capacity in North America, to continue to build its European Union campus in Portugal, and to expand availability of its products to more patients and pharmacies around the globe.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
1100 Maughan Rd.
Nanaimo BC, V9X 1J2
Canada
Nanaimo BC, V9X 1J2
Canada
Phone
Website
Email Address
Not Recorded
Overview
Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. We are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers on four continents.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brendan Kennedy
Chief Scientific Officer
Josh Eades
VP - Bus. Development
Sean Carney
VP - Bus. Development
Marla Luther
VP - General Counsel
Christy Zhou
VP - Operations
Scott Krompocker
VP - R & D
Philippe Lucas
VP - Regulatory Affairs
Catherine Jacobson
VP - Sales
John Andonoff
VP - Sales
Woody Pastorius
Browse more venture capital transactions:
Prev: 2/9/2018: Insights Network venture capital transaction
Next: 2/9/2018: Apical Technology venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs